Therapeutic Processes in iCBT for SAD
Study Details
Study Description
Brief Summary
The current study examines therapeutic processes during internet-based cognitive-behavioral therapy for social anxiety disorder. Participants will be randomized to either treatment or wait-list conditions. Participants in the wait-list condition will receive active treatment following the wait-list period.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Internet-based cognitive-behavioral therapy (iCBT) is an effective treatment for social anxiety disorder (SAD). However, little is known about the processes and mechanisms of change in this treatment. Compared to face to face (FTF) treatments, online interventions may operate through partially different mechanisms of change due to the text-based nature of the interaction and the reduced level of therapist involvement. The present randomized controlled trial will examine therapeutic processes during iCBT for SAD including the presence of sudden gains and their relationship to outcome, the relationship between anxiety and depressive symptoms along the course of treatment, changes in the therapeutic alliance and attrition from therapy. Moreover, we will compare iCBT for SAD with a wait-list control group and utilize weekly measurements of anxiety, depression, and SAD-related cognitions in both groups. This will facilitate comparison between temporal processes in both conditions and also shed light on processes occurring in wait-list conditions.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| No Intervention: Wait list Wait list condition with no active treatment, length of 10 weeks, with weekly measurements. |
|
| Experimental: Intervention- active treatment Internet delivered CBT for social anxiety disorder |
Behavioral: Internet delivered CBT for social anxiety disorder
An internet-based CBT for social anxiety based on a protocol from Andersson et al., 2006:
"Internet-based self-help with therapist feedback and in vivo group exposure for social phobia: a randomized controlled trial."
|
Outcome Measures
Primary Outcome Measures
- Social anxiety severity [Change from Baseline LSAS at post treatment (12 weeks)]
Post treatment Liebowitz Social Anxiety Scale (LSAS). Score ranges from 0 to 144 where higher score indicates more sever social anxiety
- Diagnosis of SAD based on clinical interview [Change from Baseline ADIS diagnosis at post treatment (12 weeks)]
Diagnoses derived from the Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS)
- Social anxiety severity [Change from Baseline LSAS at 6 months follow-up]
Follow-up Liebowitz Social Anxiety Scale (LSAS). Score ranges from 0 to 144 where higher score indicates more sever social anxiety
Secondary Outcome Measures
- Social anxiety severity - additional measure [Change from Baseline SPIN at post treatment (12 weeks)]
Post treatment Social Phobia Inventory (SPIN). Score ranges from 0 to 68 where higher score indicates more sever social anxiety
- Social anxiety severity - additional measure [Change from Baseline SPIN at 6 months follow-up]
Post treatment Social Phobia Inventory (SPIN). Score ranges from 0 to 68 where higher score indicates more sever social anxiety
Other Outcome Measures
- Depressive symptoms severity [Change from Baseline BDI-II at post treatment (12 weeks)]
Post treatment Beck Depression Inventory II, (BDI-II). Score ranges from 0 to 63 where higher score indicates more sever depression.
- Depressive symptoms severity [Change from Baseline BDI-II at 6 months follow-up]
Post treatment Beck Depression Inventory II, (BDI-II). Score ranges from 0 to 63 where higher score indicates more sever depression.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Meeting DSM-5 criteria for social anxiety disorder.
-
Fluency in Hebrew
-
Access to internet
Exclusion Criteria:
-
Substance use disorders
-
Past or present psychosis
-
High levels of suicidality
-
Changes in pharmacological treatment 3 months or less prior to the start of the trial
-
Participation in other psychotherapeutic treatments during the trial
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University of Haifa | Haifa | Israel |
Sponsors and Collaborators
- University of Haifa
- Hebrew University of Jerusalem
- Linkoeping University
Investigators
- Principal Investigator: Idan M Aderka, PhD, University of Haifa
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- UHaifaCBT